We improve patient lives by unlocking the tissue phenome.

In oncology, therapeutic strategies have shifted from a direct assault on cancer cells to recruiting the immune system for that purpose. Our mission is to accelerate breakthroughs for this approach by helping scientists leverage Tissue Phenomics to deepen understanding of disease biology and immune system mechanisms, to bring multi-omics data into a cancer-relevant context, and to facilitate the translation of new insights into novel therapies and treatment strategies. Our vision is to create unique patient profiles for an individualized standard of care, where patients experience fewer side effects and live longer.

Definiens' Tissue Phenomics approach was awarded the 2013 Frost and Sullivan Company of the Year Award for Global Tissue Diagnostics and Pathology Imaging. For more information, please visit: www.definiens.com.

Do you want to share our pioneering vision and be part of this significant approach?

Current Job Openings at Definiens

IT

Manager IT Support Services (m/f)
Definiens AG Munich

Medical

Experienced Biostatistician (m/f)
Definiens AG Munich
Staff Pathologist (m/f)
Definiens AG Munich

Product Development

Validation Manager (m/f)
Definiens AG Munich

Product Marketing

Professional Services

Share this page: